Bleeding and bruising in Osteogenesis Imperfecta: International Society on Thrombosis and Haemostasis bleeding assessment tool and haemostasis laboratory assessment in 22 individuals

被引:14
|
作者
Gooijer, Koert [1 ]
Rondeel, Jan M. M. [2 ]
van Dijk, Fleur S. [1 ,3 ]
Harsevoort, Arjan G. J. [1 ]
Janus, Guus J. M. [1 ]
Franken, Anton A. M. [1 ]
机构
[1] Isala Hosp, Expert Ctr Adults Osteogenesis Imperfecta, Zwolle, Netherlands
[2] Isala Hosp, Dept Clin Chem, Zwolle, Netherlands
[3] North West Hlth Care Univ NHS Trust, Ehlers Danlos Syndrome Natl Diagnost Serv London, North West Thames Reg Genet Serv, Harrow, Middx, England
关键词
blood coagulation disorders; capillary fragility; fibrinolysis; hemorrhage; Osteogenesis Imperfecta; PLATELET-FUNCTION; PATIENT; DISEASE; HEMORRHAGE; MUTATIONS; DIAGNOSIS; UTILITY;
D O I
10.1111/bjh.16097
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteogenesis imperfecta (OI) is characterized by susceptibility to bone fractures. Other symptoms, such as easy bruising and bleeding complications during surgery necessitating transfusions, have also been reported. The aim of the cross-sectional pilot study was to assess the bleeding and bruising tendency in OI patients and to screen for possible underlying haematological disorders. Bleeding tendency was investigated using the International Society on Thrombosis and Haemostasis bleeding assessment tool (ISTH-BAT) in 22 adult OI patients. Laboratory testing was performed to investigate for bleeding disorders or abnormal coagulation. Four patients [OI type 1(n = 3), OI type 4(n = 1)] had a bleeding score (BS) fitting with a bleeding tendency, but without test results pointing to a coagulopathy. Two patients [OI type 1(n = 1), OI type 3 (n = 1)] without a bleeding tendency according to the BS had increased fibrinolysis. This is the second largest study to date addressing bleeding tendency in OI and the first study to use ISTH-BAT and elaborate laboratory testing for coagulopathies. Four patients had an increased bleeding tendency. However, laboratory testing demonstrated no bleeding disorder or abnormal coagulation. Increased fibrinolysis was demonstrated in two patients without bleeding tendency on BS. Vascular fragility as a cause of bleeding tendency in OI has been suggested earlier. Further research on bleeding tendency in OI is important.
引用
收藏
页码:509 / 517
页数:9
相关论文
共 39 条
  • [31] The Prognostic Value of Bleeding Academic Research Consortium (BARC)-Defined Bleeding Complications in ST-Segment Elevation Myocardial Infarction A Comparison With the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) Bleeding Classifications
    Kikkert, Wouter J.
    van Geloven, Nan
    van der Laan, Mariet H.
    Vis, Marije M.
    Baan, Jan, Jr.
    Koch, Karel T.
    Peters, Ron J.
    de Winter, Robbert J.
    Piek, Jan J.
    Tijssen, Jan G. P.
    Henriques, Jose P. S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (18) : 1866 - 1875
  • [32] Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR)
    Godier, Anne
    Garrigue, Delphine
    Lasne, Dominique
    Fontana, Pierre
    Bonhomme, Fanny
    Collet, Jean-Philippe
    de Maistre, Emmanuel
    Ickx, Brigitte
    Gruel, Yves
    Mazighi, Mikael
    Nguyen, Philippe
    Vincentelli, Andre
    Albaladejo, Pierre
    Lecompte, Thomas
    Belisle, S.
    Blais, N.
    Borel-Derlon, A.
    Borg, J. Y.
    Bosson, J-L
    Cohen, A.
    Faraoni, D.
    Huet, D. Garrigue
    Guay, J.
    Hardy, J. F.
    Huet, Y.
    Laporte, S.
    Levy, J. H.
    Llau, J.
    Le Gal, G.
    Lessire, S.
    Longrois, D.
    Madi-Jebara, S.
    Marret, E.
    Mas, J. L.
    Meyer, G.
    Mismetti, P.
    Morange, P. E.
    Motte, S.
    Mullier, F.
    Nathan, N.
    Ozier, Y.
    Pernod, G.
    Rosencher, N.
    Roullet, S.
    Roy, P. M.
    Samama, C. M.
    Schlumberger, S.
    Schved, J. F.
    Sie, R.
    Steib, A.
    ANESTHESIE & REANIMATION, 2019, 5 (03): : 218 - 237
  • [33] Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation - On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH)
    Taylor, FB
    Toh, CH
    Hoots, WK
    Wada, H
    Levi, M
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (05) : 1327 - 1330
  • [34] Laboratory assessment of warfarin reversal with global coagulation tests versus international normalized ratio in patients with intracranial bleeding
    Voils, Stacy A.
    Martin, Erika J.
    Mohammed, Bassem M.
    Bayrlee, Ahmad
    Brophy, Donald F.
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (04) : 443 - 447
  • [35] Evaluation of ISTH-bleeding assessment tool in individuals with suspected inherited platelet function disorder referred to tertiary health care facility in Pakistan
    Rashid, A.
    Moiz, B.
    Rizvi, B.
    Perveen, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 920 - 921
  • [36] Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis
    Lip, Gregory Y. H.
    Andreotti, Felicita
    Fauchier, Laurent
    Huber, Kurt
    Hylek, Elaine
    Knight, Eve
    Lane, Deirdre A.
    Levi, Marcel
    Marin, Francisco
    Palareti, Gualtiero
    Kirchhof, Paulus
    Collet, Jean-Philippe
    Rubboli, Andrea
    Poli, Daniela
    Camm, John
    EUROPACE, 2011, 13 (05): : 723 - 746
  • [37] Recombinant Factor VIIa (rFVIIa) Is Safe and Effective When Used to Treat Acute Bleeding Episodes and to Prevent Bleeding During Surgery in Patients with Acquired Hemophilia: Updated Assessment From the Hemostasis and Thrombosis Research Society (HTRS) Registry AH Database
    Ma, Alice D.
    Kessler, Craig M.
    Gut, Robert Z.
    Cooper, David L.
    BLOOD, 2011, 118 (21) : 1447 - 1447
  • [38] Bleeding risk assessment and management in atrial fibrillation patients Executive Summary* of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis
    Lip, Gregory Y. H.
    Andreotti, Felicita
    Fauchier, Laurent
    Huber, Kurt
    Hylek, Elaine
    Knight, Eve
    Lane, Deirdre
    Levi, Marcel
    Marin, Francisco
    Palareti, Gualtiero
    Kirchhof, Paulus
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (06) : 997 - 1011
  • [39] Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society
    Gorog, Diana A.
    Gue, Ying X.
    Chao, Tze-Fan
    Fauchier, Laurent
    Ferreiro, Jose Luis
    Huber, Kurt
    Konstantinidis, Stavros, V
    Lane, Deirdre A.
    Marin, Francisco
    Oldgren, Jonas
    Potpara, Tatjana
    Roldan, Vanessa
    Rubboli, Andrea
    Sibbing, Dirk
    Tse, Hung-Fat
    Vilahur, Gemma
    Lip, Gregory Y. H.
    EUROPACE, 2022, 24 (11): : 1844 - 1871